iCAD to Merge with CADx and Qualia Computing
|
By HospiMedica staff writers Posted on 15 Dec 2003 |
An agreement has been announced whereby iCAD, Inc. (Nashua, NH, USA; www.icad.med.com) will merge with privately held CADx (Beavercreek, OH, USA) and Qualia Computing, Inc. (also in Beavercreek). Currently, the companies are working on a joint and coordinated basis.
The combination of iCAD and CADx represents a merger of two growing computer-aided detection (CAD) companies with complementary strengths and minimal duplication of activities. iCAD and CADx have installed more than 300 CAD systems for the early detection of breast cancer. CADx anticipates profitable operations in the fourth quarter of 2003 and in 2004, while iCAD has projected profitable operations for 2004. To complete the merger, iCAD will issue 4.3 million shares of its common stock in exchange for all outstanding shares of Qualia Computing, Inc. and CADx System, Inc. In addition, iCAD will pay U.S.$1.55 million in cash and execute a 36-month promissory note in the amount of $4.5 million to purchase Qualia shares owned by two institutional investors. CADx will operate as an independent subsidiary of iCAD, Inc.
"The benefits of this merger for CADx and its customers include access to iCAD's new iQ technology, which allows all women's healthcare facilities, regardless of size, to offer CAD solutions to women at risk,” said Dr. Steven Rogers, president and CEO of CADx and Qualia Computing.
Related Links:
ICAD
CADx
Qualia Computing
The combination of iCAD and CADx represents a merger of two growing computer-aided detection (CAD) companies with complementary strengths and minimal duplication of activities. iCAD and CADx have installed more than 300 CAD systems for the early detection of breast cancer. CADx anticipates profitable operations in the fourth quarter of 2003 and in 2004, while iCAD has projected profitable operations for 2004. To complete the merger, iCAD will issue 4.3 million shares of its common stock in exchange for all outstanding shares of Qualia Computing, Inc. and CADx System, Inc. In addition, iCAD will pay U.S.$1.55 million in cash and execute a 36-month promissory note in the amount of $4.5 million to purchase Qualia shares owned by two institutional investors. CADx will operate as an independent subsidiary of iCAD, Inc.
"The benefits of this merger for CADx and its customers include access to iCAD's new iQ technology, which allows all women's healthcare facilities, regardless of size, to offer CAD solutions to women at risk,” said Dr. Steven Rogers, president and CEO of CADx and Qualia Computing.
Related Links:
ICAD
CADx
Qualia Computing
Latest Business News
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreCritical Care
view channel
Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
Remote cardiac monitoring requires comfort, wearability, and adherence to gather electrocardiogram data for clinical review. Mailing devices back for data processing can delay review. Faster insights,... Read more
Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
Continuous monitoring of metabolic biomarkers is vital in intensive care and emergency settings, yet many methods rely on separate devices and delayed laboratory analysis. Glucose trends guide diabetes... Read moreSurgical Techniques
view channel
Early “Heart Training” Surgery Promotes Regeneration in Pediatric Heart Failure
Dilated cardiomyopathy, an enlargement of the heart muscle that weakens systolic function, leaves critically ill children with few effective therapies. Clinicians must often bridge prolonged heart failure... Read moreCE-Marked Stapler Designed to Improve Staple Line Integrity
Leaks and bleeding around stapled transections remain key drivers of morbidity and reintervention in gastrointestinal and thoracic surgery, prompting surgeons to reinforce staple lines to mitigate risk.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more







